The COVID-19 pandemic has put additional supply pressures on cold-chain products, such as those encapsulated by LNPs – but delays can be avoided with sufficient safety stocks, additional suppliers, and good communication.

This article was originally published in The Medicine Maker. Contributor Kim Rice is Exelead's Director of Supply Chain & Project Management